20230930-DK-Butterfly-1 (BBBYQ) 10-Q 8 Jan 15 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Nov. 29, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	BED BATH & BEYOND INC
Document Type	10-Q
Current Fiscal Year End Date	-26
Entity Common Stock, Shares Outstanding	185,601,410
Amendment Flag	FALSE
Entity Central Index Key	886158
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Well-known Seasoned Issuer	Yes
Document Period End Date	29-Nov-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Nov. 29, 2014	Mar. 01, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$1,043,838	$366,516
Short term investment securities	134,993	489,331
Merchandise inventories	3,065,774	2,578,956
Other current assets	511,228	379,807
Total current assets	4,755,833	3,814,610
Long term investment securities	94,876	87,393
Property and equipment, net	1,601,208	1,579,804
Goodwill	486,279	486,279
Other assets	397,639	387,947
Total assets	7,335,835	6,356,033
Current liabilities:
Accounts payable	1,309,002	1,104,668
Accrued expenses and other current liabilities	458,278	385,954
Merchandise credit and gift card liabilities	296,776	284,216
Current income taxes payable	14,559	60,298
Total current liabilities	2,078,615	1,835,136
Deferred rent and other liabilities	487,998	486,996
Income taxes payable	79,915	92,614
Long term debt	1,500,000
Total liabilities	4,146,528	2,414,746
Shareholders' equity:
Preferred stock - $0.01 par value; authorized - 1,000 shares; no shares issued or outstanding	0	0
Common stock - $0.01 par value; authorized - 900,000 shares; issued 336,276 and 334,941 shares, respectively; outstanding 185,601 and 205,405 shares, respectively	3,363	3,350
Additional paid-in capital	1,594,066	1,673,217
Retained earnings	9,232,315	8,595,902
Treasury stock, at cost; 150,675 and 129,536 shares, respectively	-7,621,286	-6,317,335
Accumulated other comprehensive loss	-19,151	-13,847
Total shareholders' equity	3,189,307	3,941,287
Total liabilities and shareholders' equity	$7,335,835	$6,356,033

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Nov. 29, 2014	Mar. 01, 2014
In Thousands, except Per Share data, unless otherwise specified
Preferred stock par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	1,000	1,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock par value (in Dollars per share)	$0.01	$0.01
Common stock, shares authorized	900,000	900,000
Common stock, shares issued	336,276	334,941
Common stock, shares outstanding	185,601	205,405
Treasury stock, shares	150,675	129,536

Consolidated_Statements_of_Ear

Consolidated Statements of Earnings (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Nov. 29, 2014	Nov. 30, 2013	Nov. 29, 2014	Nov. 30, 2013
Net sales	$2,942,980	$2,864,837	$8,544,583	$8,300,649
Cost of sales	1,814,006	1,743,147	5,250,679	5,032,504
Gross profit	1,128,974	1,121,690	3,293,904	3,268,145
Selling, general and administrative expenses	776,291	747,043	2,271,779	2,180,631
Operating profit	352,683	374,647	1,022,125	1,087,514
Interest (expense) income, net	-19,569	1,314	-31,191	-586
Earnings before provision for income taxes	333,114	375,961	990,934	1,086,928
Provision for income taxes	107,706	138,764	354,521	397,937
Net earnings	$225,408	$237,197	$636,413	$688,991
Net earnings per share - Basic (in Dollars per share)	$1.24	$1.13	$3.34	$3.24
Net earnings per share - Diluted (in Dollars per share)	$1.23	$1.12	$3.31	$3.20
Weighted average shares outstanding - Basic (in Shares)	181,629	209,704	190,292	212,430
Weighted average shares outstanding - Diluted (in Shares)	183,794	212,315	192,463	215,116

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Nov. 29, 2014	Nov. 30, 2013	Nov. 29, 2014	Nov. 30, 2013
Net earnings	$225,408	$237,197	$636,413	$688,991
Other comprehensive income (loss):
Change in temporary impairment of auction rate securities, net of taxes	205	280	74	-608
Pension adjustment, net of taxes	252	1,208	700	1,571
Currency translation adjustment	-8,990	-1,197	-6,078	-5,270
Other comprehensive income (loss)	-8,533	291	-5,304	-4,307
Comprehensive income	$216,875	$237,488	$631,109	$684,684

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Nov. 29, 2014	Nov. 30, 2013
Cash Flows from Operating Activities:
Net earnings	$636,413	$688,991
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	178,742	160,672
Stock-based compensation	49,284	42,078
Tax benefit from stock-based compensation	6,540	12,676
Deferred income taxes	-27,190	6,275
Other	-1,399	-1,007
Increase in assets, net of effect of acquisitions:
Merchandise inventories	-486,818	-415,347
Trading investment securities	-7,364	-10,702
Other current assets	-105,446	-101,907
Other assets	-1,058	-5,478
Increase (decrease) in liabilities, net of effect of acquisitions:
Accounts payable	235,982	244,761
Accrued expenses and other current liabilities	66,246	24,301
Merchandise credit and gift card liabilities	12,560	15,851
Income taxes payable	-58,438	-66,284
Deferred rent and other liabilities	6,143	7,056
Net cash provided by operating activities	504,197	601,936
Cash Flows from Investing Activities:
Purchase of held-to-maturity investment securities	-219,353	-682,339
Redemption of held-to-maturity investment securities	573,750	909,375
Capital expenditures	-230,993	-228,928
Investment in unconsolidated joint venture		-3,436
Net cash provided by (used in) investing activities	123,404	-5,328
Cash Flows from Financing Activities:
Proceeds from exercise of stock options	24,790	54,431
Proceeds from issuance of senior unsecured notes	1,500,000
Payment of deferred financing costs	-10,092
Prepayment under share repurchase agreement	-165,000
Excess tax benefit from stock-based compensation	3,974	7,293
Repurchase of common stock, including fees	-1,303,951	-752,239
Net cash provided by (used in) financing activities	49,721	-690,515
Net increase (decrease) in cash and cash equivalents	677,322	-93,907
Cash and cash equivalents:
Beginning of period	366,516	564,971
End of period	$1,043,838	$471,064

Note_1_Basis_of_Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Nov. 29, 2014
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1) Basis of Presentation
	The accompanying consolidated financial statements have been prepared without audit. In the opinion of management, the accompanying consolidated financial statements contain all adjustments (consisting of only normal recurring accruals and elimination of intercompany balances and transactions) necessary to present fairly the financial position of Bed Bath & Beyond Inc. and subsidiaries (the "Company") as of November 29, 2014 and March 1, 2014 and the results of its operations and comprehensive income for the three and nine months ended November 29, 2014 and November 30, 2013, respectively, and its cash flows for the nine months ended November 29, 2014 and November 30, 2013, respectively.
	The accompanying unaudited consolidated financial statements are presented in accordance with the requirements for Form 10-Q and consequently do not include all the disclosures normally required by U.S. generally accepted accounting principles (“GAAP”). Reference should be made to Bed Bath & Beyond Inc.'s Annual Report on Form 10-K for the fiscal year ended March 1, 2014 for additional disclosures, including a summary of the Company's significant accounting policies, and to subsequently filed Forms 8-K.
	Certain reclassifications have been made to the fiscal 2013 consolidated balance sheet to conform to the fiscal 2014 consolidated balance sheet presentation.
	The Company accounts for its operations as two operating segments: North American Retail and Institutional Sales. The Institutional Sales operating segment, which is comprised of Linen Holdings, does not meet the quantitative thresholds under GAAP and therefore is not a reportable segment.

Note_2_Fair_Value_Measurements

Note 2 - Fair Value Measurements	9 Months Ended
	Nov. 29, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	2) Fair Value Measurements
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., “the exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various valuation approaches, including quoted market prices and discounted cash flows. The hierarchy for inputs used in measuring fair value maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs are inputs that reflect a company’s judgment concerning the assumptions that market participants would use in pricing the asset or liability developed based on the best information available under the circumstances. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an asset or liability must be classified in its entirety based on the lowest level of input that is significant to the measurement of fair value. The fair value hierarchy is broken down into three levels based on the reliability of inputs as follows:
	• Level 1 – Valuations based on quoted prices in active markets for identical instruments that the Company is able to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
	• Level 2 – Valuations based on quoted prices in active markets for instruments that are similar, or quoted prices in markets that are not active for identical or similar instruments, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
	• Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
	As of November 29, 2014, the Company’s financial assets utilizing Level 1 inputs include long term trading investment securities traded on active securities exchanges. The Company did not have any financial assets utilizing Level 2 inputs. Financial assets utilizing Level 3 inputs included long term investments in auction rate securities consisting of preferred shares of closed end municipal bond funds (See “Investment Securities,” Note 4).
	Fair Value of Financial Instruments
	The Company’s financial instruments include cash and cash equivalents, investment securities, accounts payable, long term debt and certain other liabilities. The Company’s investment securities consist primarily of U.S. Treasury securities, which are stated at amortized cost, and auction rate securities, which are stated at their approximate fair value. The book value of the financial instruments, excluding the Company’s long term debt, is representative of their fair values. The fair value of the Company’s long term debt is approximately $1.525 billion, which is based on quoted prices in active markets for identical instruments (i.e., Level 1 valuation), compared to the carrying value of approximately $1.500 billion.

Note_3_Cash_and_Cash_Equivalen

Note 3 - Cash and Cash Equivalents	9 Months Ended
	Nov. 29, 2014
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents Disclosure [Text Block]	3) Cash and Cash Equivalents
	Included in cash and cash equivalents are credit and debit card receivables from banks, which typically settle within five business days, of $199.0 million and $87.4 million as of November 29, 2014 and March 1, 2014, respectively.

Note_4_Investment_Securities

Note 4 - Investment Securities	9 Months Ended
	Nov. 29, 2014
Investments, Debt and Equity Securities [Abstract]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	4) Investment Securities
	The Company’s investment securities as of November 29, 2014 and March 1, 2014 are as follows:
	(in millions)	November 29,		March 1,
		2014		2014
	Available-for-sale securities:
	Long term	$	47.8	$	47.7
	Trading securities:
	Long term		47		39.7
	Held-to-maturity securities:
	Short term		135		489.3
	Total investment securities	$	229.8	$	576.7
	Auction Rate Securities
	As of November 29, 2014 and March 1, 2014, the Company’s available-for-sale investment securities represented approximately $51.0 million par value of auction rate securities, consisting of preferred shares of closed end municipal bond funds, less temporary valuation adjustments of approximately $3.2 million and $3.3 million, respectively. Since these valuation adjustments are deemed to be temporary, they are recorded in accumulated other comprehensive loss, net of a related tax benefit, and did not affect the Company’s net earnings.
	U.S. Treasury Securities
	As of November 29, 2014 and March 1, 2014, the Company’s short term held-to-maturity securities included approximately $135.0 million and approximately $489.3 million, respectively, of U.S. Treasury Bills with remaining maturities of less than one year. These securities are stated at their amortized cost which approximates fair value, which is based on quoted prices in active markets for identical instruments (i.e., Level 1 valuation).
	Long Term Trading Investment Securities
	The Company’s long term trading investment securities, which are provided as investment options to the participants of the nonqualified deferred compensation plan, are stated at fair market value. The values of these trading investment securities included in the table above are approximately $47.0 million and $39.7 million as of November 29, 2014 and March 1, 2014, respectively.

Note_5_Property_and_Equipment

Note 5 - Property and Equipment	9 Months Ended
	Nov. 29, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	5) Property and Equipment
	As of November 29, 2014 and March 1, 2014, included in property and equipment, net is accumulated depreciation of approximately $2.2 billion and $2.0 billion, respectively.

Note_6_Long_Term_Debt

Note 6 - Long Term Debt	9 Months Ended
	Nov. 29, 2014
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	6) Long Term Debt
	Senior Unsecured Notes
	On July 17, 2014, the Company issued $300 million aggregate principal amount of 3.749% senior unsecured notes due August 1, 2024 (the “2024 Notes”), $300 million aggregate principal amount of 4.915% senior unsecured notes due August 1, 2034 (the “2034 Notes”) and $900 million aggregate principal amount of 5.165% senior unsecured notes due August 1, 2044 (the “2044 Notes” and, together with the 2024 Notes and the 2034 Notes, the “Notes”). The aggregate net proceeds from the Notes were approximately $1.5 billion, which was used for share repurchases of the Company’s common stock and for general corporate purposes. Interest on the Notes is payable semi-annually on February 1 and August 1 of each year, beginning on February 1, 2015.
	The Notes were issued under an indenture (the “Base Indenture”), as supplemented by a first supplemental indenture (together, with the Base Indenture, the “Indenture”), which contains various restrictive covenants, which are subject to important limitations and exceptions that are described in the Indenture.
	The Notes are unsecured, senior obligations and rank equal in right of payment to any of the Company’s existing and future senior unsecured indebtedness. The Company may redeem the Notes at any time, in whole or in part, at the redemption prices described in the Indenture plus accrued and unpaid interest to the redemption date. If a change in control triggering event, as defined by the Indenture governing the Notes, occurs unless the Company has exercised its right to redeem the Notes, the Company will be required to make an offer to the holders of the Notes to purchase the Notes at 101% of their principal amount, plus accrued and unpaid interest.
	Revolving Credit Agreement
	On August 6, 2014, the Company entered into a $250 million five year senior unsecured revolving credit facility agreement (“Revolver”) with various lenders. During the period from August 6, 2014 through November 29, 2014, the Company did not have any borrowings under the Revolver.
	Borrowings under the Revolver accrue interest at either (1) a fluctuating rate equal to the greater of the prime rate, as defined in the Revolver, the Federal Funds Rate plus 0.50%, or one-month LIBOR plus 1.0% and, in each case, plus an applicable margin based upon the Company’s leverage ratio which is calculated quarterly, (2) a periodic fixed rate equal to LIBOR plus an applicable margin based upon the Company’s leverage ratio which is calculated quarterly or (3) an agreed upon fixed rate. In addition, a commitment fee is assessed, which is included in interest (expense) income, net in the Consolidated Statement of Earnings. The Revolver contains customary affirmative and negative covenants and also requires the Company to maintain a minimum leverage ratio. The Company was in compliance with all covenants related to the Revolver as of November 29, 2014.
	Deferred financing costs associated with the Notes and the Revolver of approximately $10.1 million were capitalized and are included in other assets in the accompanying Consolidated Balance Sheet. These deferred financing costs are being amortized over the term of each of the Notes and the term of the Revolver and such amortization is included in interest (expense) income, net in the Consolidated Statement of Earnings. Interest expense related to the Notes and the Revolver, including the commitment fee and the amortization of the deferred financing costs, was approximately $18.1 million for the three months ended November 29, 2014 and $26.8 million for the period from July 17, 2014 through November 29, 2014.
	Lines of Credit
	At November 29, 2014, the Company maintained two uncommitted lines of credit of $100 million each, with expiration dates of February 28, 2015 and September 1, 2015, respectively. These uncommitted lines of credit are currently and are expected to be used for letters of credit in the ordinary course of business. During the first nine months of fiscal 2014, the Company did not have any direct borrowings under the uncommitted lines of credit. Although no assurances can be provided, the Company intends to renew both uncommitted lines of credit before the respective expiration dates.

Note_7_Shareholders_Equity

Note 7 - Shareholders' Equity	9 Months Ended
	Nov. 29, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	7) Shareholders’ Equity
	Between December 2004 and July 2014, the Company’s Board of Directors authorized, through several share repurchase programs, the repurchase of $9.450 billion of its shares of common stock. On July 17, 2014, the Company entered into an accelerated share repurchase agreement (“ASR”) with an investment bank to repurchase an aggregate $1.1 billion of the Company’s common stock. As part of the ASR, the Company received an initial delivery of approximately 15.4 million shares of the Company’s common stock with a fair market value of approximately $935 million, which is included in treasury stock in the accompanying Consolidated Balance Sheet as of November 29, 2014. The initial delivery of 15.4 million shares reduced the outstanding shares used to determine the Company’s weighted average shares outstanding for purposes of calculating basic and diluted earnings per share. The remaining $165 million of the aggregate repurchase amount was accounted for as a reduction in additional paid-in capital in the accompanying Consolidated Balance Sheet as of November 29, 2014. In December 2014, subsequent to the end of the fiscal third quarter, the ASR was completed and the final number of shares repurchased under the ASR was based on the Company’s volume weighted average price per its common share over the ASR period less a discount.
	The Company has authorization to make repurchases from time to time in the open market or through other parameters approved by the Board of Directors pursuant to existing rules and regulations. The Company also purchases shares of its common stock to cover employee related taxes withheld on vested restricted stock awards. In the first nine months of fiscal 2014, including the initial delivery of approximately 15.4 million shares under the ASR, the Company repurchased approximately 21.1 million shares of its common stock for a total cost of approximately $1.3 billion, bringing the aggregate total of common stock repurchased to approximately 150.7 million shares for a total cost of approximately $7.6 billion since the initial authorization in December 2004. The Company has approximately $1.8 billion remaining of authorized share repurchases as of November 29, 2014.

Note_8_StockBased_Compensation

Note 8 - Stock-Based Compensation	9 Months Ended
	Nov. 29, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	8) Stock-Based Compensation
	The Company measures all employee stock-based compensation awards using a fair value method and records such expense, net of estimated forfeitures, in its consolidated financial statements. Currently, the Company’s stock-based compensation relates to restricted stock awards, stock options and performance share units. The Company’s restricted stock awards are considered nonvested share awards.
	Stock-based compensation expense for the three and nine months ended November 29, 2014 was approximately $15.5 million ($10.5 million after tax or $0.06 per diluted share) and approximately $49.3 million ($31.7 million after tax or $0.16 per diluted share), respectively. Stock-based compensation expense for the three and nine months ended November 30, 2013 was approximately $13.6 million ($8.6 million after tax or $0.04 per diluted share) and approximately $42.1 million ($26.7 million after tax or $0.12 per diluted share), respectively. In addition, the amount of stock-based compensation cost capitalized for the nine months ended November 29, 2014 and November 30, 2013 was approximately $1.3 million and $1.2 million, respectively.
	Incentive Compensation Plans
	The Company currently grants awards under the Bed Bath & Beyond 2012 Incentive Compensation Plan (the “2012 Plan”), which amended and restated the Bed Bath & Beyond 2004 Incentive Compensation Plan (the “2004 Plan”). The 2012 Plan includes an aggregate of 43.2 million common shares authorized for issuance and the ability to grant incentive stock options. Outstanding awards that were covered by the 2004 Plan continue to be in effect under the 2012 Plan.
	The 2012 Plan is a flexible compensation plan that enables the Company to offer incentive compensation through stock options (whether nonqualified stock options or incentive stock options), restricted stock awards, stock appreciation rights, performance awards and other stock based awards, including cash awards. Under the 2012 Plan, grants are determined by the Compensation Committee for those awards granted to executive officers and by an appropriate committee for all other awards granted. Awards of stock options and restricted stock generally vest in five equal annual installments beginning one to three years from the date of grant. Awards of performance share units generally vest over a period of four years from the date of grant dependent on the Company’s achievement of performance-based tests and subject, in general, to the executive remaining in the Company’s service on specified vesting dates.
	The Company generally issues new shares for stock option exercises, restricted stock awards and vesting of performance share units. As of November 29, 2014, unrecognized compensation expense related to the unvested portion of the Company’s stock options, restricted stock awards and performance share units was $27.7 million, $138.6 million and $17.4 million, respectively, which is expected to be recognized over a weighted average period of 2.9 years, 3.7 years and 2.7 years, respectively.
	Stock Options
	Stock option grants are issued at fair market value on the date of grant and generally become exercisable in either three or five equal annual installments beginning one year from the date of grant for options issued since May 10, 2010, and beginning one to three years from the date of grant for options issued prior to May 10, 2010, in each case, subject, in general to the recipient remaining in the Company’s service on specified vesting dates. Option grants expire eight years after the date of grant for stock options issued since May 10, 2004, and expire ten years after the date of grant for stock options issued prior to May 10, 2004. All option grants are nonqualified.
	The fair value of the stock options granted is estimated on the date of the grant using a Black-Scholes option-pricing model that uses the assumptions noted in the following table.
		Nine Months Ended
	Black-Scholes Valuation Assumptions  (1)	November 29,			November 30,
		2014			2013
	Weighted Average Expected Life (in years)  (2)		6.6			6.6
	Weighted Average Expected Volatility  (3)		28.31	%		29.27	%
	Weighted Average Risk Free Interest Rates  (4)		2.11	%		1.11	%
	Expected Dividend Yield		-			-
	(1) Forfeitures are estimated based on historical experience.
	(2) The expected life of stock options is estimated based on historical experience.
	(3) Expected volatility is based on the average of historical and implied volatility. The historical volatility is determined by observing actual prices of the Company’s stock over a period commensurate with the expected life of the awards. The implied volatility represents the implied volatility of the Company’s call options, which are actively traded on multiple exchanges, had remaining maturities in excess of twelve months, had market prices close to the exercise prices of the employee stock options and were measured on the stock option grant date.
	(4) Based on the U.S. Treasury constant maturity interest rate whose term is consistent with the expected life of the stock options.
	Changes in the Company’s stock options for the nine months ended November 29, 2014 were as follows:
	(Shares in thousands)	Number of Stock Options			Weighted Average Exercise Price
	Options outstanding, beginning of period		4,192		$	46.85
	Granted		523			62.34
	Exercised		(644	)		38.48
	Forfeited or expired		-			-
	Options outstanding, end of period		4,071		$	50.16
	Options exercisable, end of period		2,378		$	42.54
	The weighted average fair value for the stock options granted during the first nine months of fiscal 2014 and 2013 was $20.96 and $22.28, respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options outstanding as of November 29, 2014 was 4.1 years and $94.7 million, respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options exercisable as of November 29, 2014 was 2.9 years and $73.3 million, respectively. The total intrinsic value for stock options exercised during the first nine months of fiscal 2014 and 2013 was $19.4 million and $44.4 million, respectively.
	Net cash proceeds from the exercise of stock options for the first nine months of fiscal 2014 were $24.8 million and the net associated income tax benefit was $10.5 million.
	Restricted Stock
	Restricted stock awards are issued and measured at fair market value on the date of grant and generally become vested in five equal annual installments beginning one to three years from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. Vesting of restricted stock awarded to certain of the Company’s executives is dependent on the Company’s achievement of a performance-based test for the fiscal year of grant and, assuming achievement of the performance-based test, time vesting, subject, in general, to the executive remaining in the Company’s service on specified vesting dates. The Company recognizes compensation expense related to these awards based on the assumption that the performance-based test will be achieved. Vesting of restricted stock awarded to the Company’s other employees is based solely on time vesting.
	Changes in the Company’s restricted stock for the nine months ended November 29, 2014 were as follows:
	(Shares in thousands)	Number of Restricted Shares			Weighted Average Grant-Date Fair Value
	Unvested restricted stock, beginning of period		3,943		$	53.66
	Granted		823			62.33
	Vested		(1,010	)		45
	Forfeited		(131	)		59.91
	Unvested restricted stock, end of period		3,625		$	57.82
	Performance Share Units
	Performance share units (“PSUs”) are issued and measured at fair market value on the date of grant. Vesting of PSUs awarded to certain of the Company’s executives is dependent on the Company’s achievement of a performance-based test during a one-year period from the date of grant and during a three-year period from the date of grant and, assuming achievement of the performance-based test, time vesting, subject, in general, to the executive remaining in the Company’s service on specified vesting dates. Performance during the one-year period will be based on Earnings Before Income Tax (“EBIT”) margin relative to a peer group of the Company comprising 50 companies selected within the first 90 days of the performance period. Upon achievement of the one-year performance-based test, the corresponding PSUs will vest annually in substantially equal installments over a three year period starting one year from the date of grant. Performance during the three-year period will be based on Return on Invested Capital (“ROIC”) relative to such peer group. Upon achievement of the three-year performance-based test, the corresponding PSUs will vest on the fourth anniversary date of grant. The awards based on EBIT margin and ROIC are capped at 150% of target achievement, with a floor of zero. PSUs are converted into shares of common stock upon payment following vesting. Upon grant of the PSUs, the Company recognizes compensation expense related to these awards based on the assumption that 100% of the target award will be achieved. The Company evaluates the target assumption on a quarterly basis and adjusts compensation expense related to these awards, as appropriate. Prior to the first quarter of fiscal 2014, the Company had not granted any PSUs. For the nine months ended November 29, 2014, the Company granted 390,803 PSUs with a weighted average grant date fair value of $62.34.

Note_9_Earnings_Per_Share

Note 9 - Earnings Per Share	9 Months Ended
	Nov. 29, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	9) Earnings Per Share
	The Company presents earnings per share on a basic and diluted basis. Basic earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding. Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding, including the dilutive effect of stock-based awards as calculated under the treasury stock method.
	Stock-based awards for the three and nine months ended November 29, 2014 of approximately 1.6 million and 1.9 million, respectively, and for the three and nine months ended November 30, 2013 of approximately 1.0 million and 1.2 million, respectively, were excluded from the computation of diluted earnings per share as the effect would be anti-dilutive.

Note_10_Supplemental_Cash_Flow

Note 10 - Supplemental Cash Flow Information	9 Months Ended
	Nov. 29, 2014
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	10) Supplemental Cash Flow Information
	The Company paid income taxes of $432.2 million and $435.9 million in the first nine months of fiscal 2014 and 2013, respectively. In addition, the Company had interest payments of approximately $6.8 million and $6.9 million in the first nine months of fiscal 2014 and 2013, respectively.
	The Company recorded an accrual for capital expenditures of $18.5 million and $24.1 million as of November 29, 2014 and November 30, 2013, respectively.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	9 Months Ended
	Nov. 29, 2014
Accounting Policies [Abstract]
Fair Value Measurement, Policy [Policy Text Block]	2) Fair Value Measurements
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., “the exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various valuation approaches, including quoted market prices and discounted cash flows. The hierarchy for inputs used in measuring fair value maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs are inputs that reflect a company’s judgment concerning the assumptions that market participants would use in pricing the asset or liability developed based on the best information available under the circumstances. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an asset or liability must be classified in its entirety based on the lowest level of input that is significant to the measurement of fair value. The fair value hierarchy is broken down into three levels based on the reliability of inputs as follows:
	• Level 1 – Valuations based on quoted prices in active markets for identical instruments that the Company is able to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
	• Level 2 – Valuations based on quoted prices in active markets for instruments that are similar, or quoted prices in markets that are not active for identical or similar instruments, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
	• Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
	As of November 29, 2014, the Company’s financial assets utilizing Level 1 inputs include long term trading investment securities traded on active securities exchanges. The Company did not have any financial assets utilizing Level 2 inputs. Financial assets utilizing Level 3 inputs included long term investments in auction rate securities consisting of preferred shares of closed end municipal bond funds (See “Investment Securities,” Note 4).
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments
	The Company’s financial instruments include cash and cash equivalents, investment securities, accounts payable, long term debt and certain other liabilities. The Company’s investment securities consist primarily of U.S. Treasury securities, which are stated at amortized cost, and auction rate securities, which are stated at their approximate fair value. The book value of the financial instruments, excluding the Company’s long term debt, is representative of their fair values. The fair value of the Company’s long term debt is approximately $1.525 billion, which is based on quoted prices in active markets for identical instruments (i.e., Level 1 valuation), compared to the carrying value of approximately $1.500 billion.

Note_4_Investment_Securities_T

Note 4 - Investment Securities (Tables)	9 Months Ended
	Nov. 29, 2014
Investments, Debt and Equity Securities [Abstract]
Marketable Securities [Table Text Block]	(in millions)	November 29,		March 1,
		2014		2014
	Available-for-sale securities:
	Long term	$	47.8	$	47.7
	Trading securities:
	Long term		47		39.7
	Held-to-maturity securities:
	Short term		135		489.3
	Total investment securities	$	229.8	$	576.7

Note_8_StockBased_Compensation1

Note 8 - Stock-Based Compensation (Tables)	9 Months Ended
	Nov. 29, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]		Nine Months Ended
	Black-Scholes Valuation Assumptions  (1)	November 29,			November 30,
		2014			2013
	Weighted Average Expected Life (in years)  (2)		6.6			6.6
	Weighted Average Expected Volatility  (3)		28.31	%		29.27	%
	Weighted Average Risk Free Interest Rates  (4)		2.11	%		1.11	%
	Expected Dividend Yield		-			-
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	(Shares in thousands)	Number of Stock Options			Weighted Average Exercise Price
	Options outstanding, beginning of period		4,192		$	46.85
	Granted		523			62.34
	Exercised		(644	)		38.48
	Forfeited or expired		-			-
	Options outstanding, end of period		4,071		$	50.16
	Options exercisable, end of period		2,378		$	42.54
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	(Shares in thousands)	Number of Restricted Shares			Weighted Average Grant-Date Fair Value
	Unvested restricted stock, beginning of period		3,943		$	53.66
	Granted		823			62.33
	Vested		(1,010	)		45
	Forfeited		(131	)		59.91
	Unvested restricted stock, end of period		3,625		$	57.82

Note_1_Basis_of_Presentation_D

Note 1 - Basis of Presentation (Details)	9 Months Ended
	Nov. 29, 2014
Disclosure Text Block [Abstract]
Number of Operating Segments	2

Note_2_Fair_Value_Measurements1

Note 2 - Fair Value Measurements (Details) (USD $)	Nov. 29, 2014
Fair Value Disclosures [Abstract]
Long-term Debt, Fair Value	$1,525,000,000
Long-term Debt, Excluding Current Maturities	$1,500,000,000

Note_3_Cash_and_Cash_Equivalen1

Note 3 - Cash and Cash Equivalents (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Nov. 29, 2014	Mar. 01, 2014
Cash and Cash Equivalents [Abstract]
Number of Business Days for Settlement of Credit and Debit Card Receivables	5 days
Credit and Debit Card Receivables, at Carrying Value	$199	$87.40

Note_4_Investment_Securities_D

Note 4 - Investment Securities (Details) (USD $)	Nov. 29, 2014	Mar. 01, 2014
In Millions, unless otherwise specified
Note 4 - Investment Securities (Details) [Line Items]
Held-to-maturity Securities, Current	$135	$489.30
Deferred Compensation Plan Assets	47	39.7
Auction Rate Securities [Member]
Note 4 - Investment Securities (Details) [Line Items]
Available-for-Sale Securities, Equity Securities At Par Value	51	51
Available-for-Sale Securities, Temporary Impairment Adjustment, Accumulated Other Comprehensive Income (Loss)	3.2	3.3
US Treasury Securities [Member]
Note 4 - Investment Securities (Details) [Line Items]
Held-to-maturity Securities, Current	135	489.3
Other Trading Investment Securities [Member]
Note 4 - Investment Securities (Details) [Line Items]
Deferred Compensation Plan Assets	$47	$39.70

Note_4_Investment_Securities_D1

Note 4 - Investment Securities (Details) - Investment Securities (USD $)	Nov. 29, 2014	Mar. 01, 2014
In Millions, unless otherwise specified
Available-for-sale securities:
Long term	$47.80	$47.70
Trading securities:
Long term	47	39.7
Held-to-maturity securities:
Short term	135	489.3
Total investment securities	$229.80	$576.70

Note_5_Property_and_Equipment_

Note 5 - Property and Equipment (Details) (USD $)	Nov. 29, 2014	Mar. 01, 2014
In Billions, unless otherwise specified
Property, Plant and Equipment [Abstract]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$2.20	$2

Note_6_Long_Term_Debt_Details

Note 6 - Long Term Debt (Details) (USD $)	9 Months Ended	0 Months Ended		3 Months Ended	4 Months Ended
	Nov. 29, 2014	Aug. 06, 2014	Jul. 17, 2014	Nov. 29, 2014	Nov. 29, 2014
Note 6 - Long Term Debt (Details) [Line Items]
Proceeds from Issuance of Long-term Debt	$1,500,000,000
Line of Credit Facility, Number Maintained	2			2	2
Other Assets [Member] | Senior Unsecured Notes and Revolver [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Deferred Finance Costs, Gross		10,100,000
Federal Funds Rate [Member] | Revolver [Member] | Revolving Credit Facility [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate		0.50%
London Interbank Offered Rate (LIBOR) [Member] | Revolver [Member] | Revolving Credit Facility [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate		1.00%
Senior Unsecured Notes [Member] | The 2024 Notes [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Debt Instrument, Face Amount			300,000,000
Debt Instrument, Interest Rate, Stated Percentage			3.75%
Debt Instrument, Maturity Date			1-Aug-24
Senior Unsecured Notes [Member] | The 2034 Notes [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Debt Instrument, Face Amount			300,000,000
Debt Instrument, Interest Rate, Stated Percentage			4.92%
Debt Instrument, Maturity Date			1-Aug-34
Senior Unsecured Notes [Member] | The 2044 Notes [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Debt Instrument, Face Amount			900,000,000
Debt Instrument, Interest Rate, Stated Percentage			5.17%
Debt Instrument, Maturity Date			1-Aug-44
Senior Unsecured Notes [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Proceeds from Issuance of Long-term Debt			1,500,000,000
Debt Instrument, Change in Control, Offer to Purchase, Principal Amount, Percentage			101.00%
Revolver [Member] | Revolving Credit Facility [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		250,000,000
Debt Instrument, Term		5 years
Senior Unsecured Notes and Revolver [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Interest Expense				18,100,000	26,800,000
Uncommitted Line of Credit Expiration Date of February 28, 2015 [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	100,000,000			100,000,000	100,000,000
Uncommitted Line of Credit Expiration Date of September 1, 2015 [Member]
Note 6 - Long Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$100,000,000			$100,000,000	$100,000,000

Note_7_Shareholders_Equity_Det

Note 7 - Shareholders' Equity (Details) (USD $)	9 Months Ended		116 Months Ended	120 Months Ended	0 Months Ended	4 Months Ended
Share data in Millions, unless otherwise specified	Nov. 29, 2014	Nov. 30, 2013	Jul. 31, 2014	Nov. 29, 2014	Jul. 17, 2014	Nov. 29, 2014
Note 7 - Shareholders' Equity (Details) [Line Items]
Stock Repurchase Program, Authorized Amount			$9,450,000,000
Payments for Repurchase of Common Stock	1,303,951,000	752,239,000		7,600,000,000
Treasury Stock, Shares, Acquired (in Shares)	21.1			150.7
Stock Repurchase Program, Remaining Authorized Repurchase Amount	1,800,000,000
ASR [Member]
Note 7 - Shareholders' Equity (Details) [Line Items]
Payments for Repurchase of Common Stock					1,100,000,000
Treasury Stock, Shares, Acquired (in Shares)						15.4
Treasury Stock, Value, Acquired, Cost Method						935,000,000
Additional Paid In Capital Stock Repurchase	$165,000,000			$165,000,000		$165,000,000

Note_8_StockBased_Compensation2

Note 8 - Stock-Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 29, 2014	Nov. 30, 2013	Nov. 29, 2014	Nov. 30, 2013	Mar. 01, 2014
Note 8 - Stock-Based Compensation (Details) [Line Items]
Allocated Share-based Compensation Expense (in Dollars)	$15,500,000	$13,600,000	$49,300,000	$42,100,000
Allocated Share-based Compensation Expense, Net of Tax (in Dollars)	10,500,000	8,600,000	31,700,000	26,700,000
Stock Based Compensation Expense Impact On Diluted Earnings Per Share (in Dollars per share)	$0.06	$0.04	$0.16	$0.12
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount (in Dollars)			1,300,000	1,200,000
Proceeds from Stock Options Exercised (in Dollars)			24,790,000	54,431,000
Scenario, Assumption [Member] | Performance Share Unit (PSUs) [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Target Award, Percentage	100.00%		100.00%
Restricted Stock [Member] | The 2012 Plan [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			5 years
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Minimum			1 year
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Maximum			3 years
Restricted Stock [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			5 years
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Minimum			1 year
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Maximum			3 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	138,600,000		138,600,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			3 years 255 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)			823,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$62.33
Employee Stock Option [Member] | The 2012 Plan [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			5 years
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Minimum			1 year
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Maximum			3 years
Employee Stock Option [Member] | Minimum [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years
Employee Stock Option [Member] | Maximum [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			5 years
Employee Stock Option [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	27,700,000		27,700,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 328 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$20.96	$22.28
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term			4 years 36 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)	94,700,000		94,700,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term			2 years 328 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value (in Dollars)	73,300,000		73,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value (in Dollars)			19,400,000	44,400,000
Proceeds from Stock Options Exercised (in Dollars)			24,800,000
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (in Dollars)			10,500,000
Performance Share Unit (PSUs) [Member] | The 2012 Plan [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			4 years
Performance Share Unit (PSUs) [Member] | Minimum [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Target Award, Percentage	0.00%		0.00%
Performance Share Unit (PSUs) [Member] | Maximum [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Target Award, Percentage	150.00%		150.00%
Performance Share Unit (PSUs) [Member] | One-Year Performance Period Awards [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Minimum			1 year
Performance Share Unit (PSUs) [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	$17,400,000		$17,400,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 255 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)			390,803		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$62.34
Employee Stock Option Issued Since May 10, 2010 [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Requisite Service Period			1 year
Employee Stock Option Issued Prior to May 10, 2010 [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Minimum			1 year
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period Maximum			3 years
Employee Stock Option Issued Since May 10, 2004 [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			8 years
Employee Stock Option Issued Prior to May 10, 2004 [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			10 years
The 2012 Plan [Member]
Note 8 - Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)	43,200,000		43,200,000

Note_8_StockBased_Compensation3

Note 8 - Stock-Based Compensation (Details) - Assumptions Used to Estimate the Black-Scholes Fair Value of Stock Options Granted	9 Months Ended
	Nov. 29, 2014		Nov. 30, 2013
Assumptions Used to Estimate the Black-Scholes Fair Value of Stock Options Granted [Abstract]
Weighted Average Expected Life (in years) (2)	6 years 219 days	[1],[2]	6 years 219 days	[1],[2]
Weighted Average Expected Volatility (3)	28.31%	[1],[3]	29.27%	[1],[3]
Weighted Average Risk Free Interest Rates (4)	2.11%	[1],[4]	1.11%	[1],[4]
Expected Dividend Yield		[1]		[1]
[1]	Forfeitures are estimated based on historical experience.
[2]	The expected life of stock options is estimated based on historical experience.
[3]	Expected volatility is based on the average of historical and implied volatility. The historical volatility is determined by observing actual prices of theCompany's stock over a period commensurate with the expected life of the awards. The implied volatility represents the implied volatility of the Company's call options, which are actively traded on multiple exchanges, had remaining maturities in excess of twelve months, had market prices close to the exercise prices of the employee stock options and were measured on the stock option grant date.
[4]	Based on the U.S. Treasury constant maturity interest rate whose term is consistent with the expected life of the stock options.

Note_8_StockBased_Compensation4

Note 8 - Stock-Based Compensation (Details) - Changes in the Companybs Stock Options (Employee Stock Option [Member], USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Nov. 29, 2014
Employee Stock Option [Member]
Note 8 - Stock-Based Compensation (Details) - Changes in the Companybs Stock Options [Line Items]
Options outstanding, beginning of period	4,192
Options outstanding, beginning of period	$46.85
Granted	523
Granted	$62.34
Exercised	-644
Exercised	$38.48
Forfeited or expired	0
Forfeited or expired
Options outstanding, end of period	4,071
Options outstanding, end of period	$50.16
Options exercisable, end of period	2,378
Options exercisable, end of period	$42.54

Note_8_StockBased_Compensation5

Note 8 - Stock-Based Compensation (Details) - Changes in the Companybs Restricted Stock (Restricted Stock [Member], USD $)	9 Months Ended
	Nov. 29, 2014
Restricted Stock [Member]
Note 8 - Stock-Based Compensation (Details) - Changes in the Companybs Restricted Stock [Line Items]
Unvested restricted stock, beginning of period	3,943,000
Unvested restricted stock, beginning of period	$53.66
Granted	823,000
Granted	$62.33
Vested	-1,010,000
Vested	$45
Forfeited	-131,000
Forfeited	$59.91
Unvested restricted stock, end of period	3,625,000
Unvested restricted stock, end of period	$57.82

Note_9_Earnings_Per_Share_Deta

Note 9 - Earnings Per Share (Details)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Nov. 29, 2014	Nov. 30, 2013	Nov. 29, 2014	Nov. 30, 2013
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1.6	1	1.9	1.2

Note_10_Supplemental_Cash_Flow1

Note 10 - Supplemental Cash Flow Information (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Nov. 29, 2014	Nov. 30, 2013
Supplemental Cash Flow Elements [Abstract]
Income Taxes Paid	$432.20	$435.90
Interest Paid	6.8	6.9
Capital Expenditures Incurred but Not yet Paid	$18.50	$24.10